| HOME >> BIOLOGY >> TECHNOLOGY |
Deferred income tax provision 719 710
Stock option expense 92 83
Provision for doubtful accounts 263 1,418
Asset writeoff charges 26 51
Changes in operating assets and liabilities
excluding effects of acquisitions:
Accounts receivable (3,700) (347)
Income tax receivable 78 (91)
Insurance receivable - (2,619)
Other current assets (189) 58
Other non-current assets 70 (39)
Accounts payable (2,773) 805
Accrued expenses (746) (1,337)
Accrued compensation (999) 409
Customer accommodation and quantification (459) (2,046)
Deferred revenue 1,441 (628)
Other non-current liabilities (70) 1,930
Net cash (used in) provided by operating
activities $(6,391) $96
Investing activities:
Purchase of property and equipment (1,837) (1,889)
Capitalized software (611) (217)
Net cash used in investing activities (2,448) (2,106)
Financing activities:
Net cash provided financing activities - -
Effect of exchange rate changes (32) 7
Net decrease in cash and cash equivalents (8,871) (2,003)
Cash and cash equivalents - beginning
'/>"/>
| SOURCE MedQuist Inc. Copyright©2008 PR Newswire. All rights reserved |